Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Benign Centrally-Located Intracranial Tumors
and you are
between 8 and 22
years old
The phase for this study is not defined.
Show me locations

The purpose

The goal of this prospective, non-randomized, single-arm, feasibility study is to develop data to evaluate the safety and feasibility of ExAblate 4000 treatment of benign intracranial tumors which require clinical intervention in pediatric and young adult subjects. Indication of Use: Ablation of benign intracranial tumors in children and young adults which are ExAblate accessible.

Provided treatments

  • Device: ExAblate 4000 System
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028246. The sponsor of the trial is InSightec and it is looking for 10 volunteers for the current phase.
Official trial title:
A Feasibility Safety Study Using the ExAblate 4000 System in the Management of Benign Centrally-Located Intracranial Tumors Which Require Clinical Intervention in Pediatric and Young Adult Subjects